⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iminoribitol SCHEMBL3401281 | 1.00 | — | — | |
| Iminoribitol SCHEMBL981088 | 1.00 | — | — | |
| Iminoribitol SCHEMBL7980149 | 1.00 | — | — | |
| Iminoribitol SCHEMBL4024089 | 1.00 | — | — | |
| Iminoribitol SCHEMBL3365896 | 1.00 | — | — | |
| Iminoribitol SCHEMBL7914375 | 1.00 | — | — | |
| Iminoribitol SCHEMBL6871626 | 1.00 | — | — | |
| Iminoribitol SCHEMBL1776241 | 1.00 | — | — | |
| Iminoribitol SCHEMBL21186377 | 1.00 | — | — | |
| Iminoribitol SCHEMBL14747289 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 340 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12527830-B2 | Method for treating and preventing ulcerative colitis and method for DAI reduction | BEIJING WEHAND-BIO PHARMACEUTICAL CO., LTD (CN) | 2026-01-20 | — | — | US | claimed |
| EP-4585222-A1 | USE OF MULBERRY EXTRACT IN PREPARATION OF DRUG FOR PREVENTING AND/OR TREATING CHRONIC KIDNEY DISEASE | Beijing Wehand-Bio Pharmaceutical Co., Ltd (CN) | 2025-07-16 | — | — | EP | claimed |
| CN-119925461-A | Application of mulberry extract in preparation of anti-aging products | 北京五和博澳药业股份有限公司 | 2025-05-06 | — | — | CN | claimed |
| CN-119925460-A | Application of mulberry extract in preparation of product for preventing and/or treating acne | 中国医学科学院药物研究所 | 2025-05-06 | — | — | CN | claimed |
| CN-119656228-A | Application of mulberry extract in preparing medicament for treating and/or preventing bone metabolism abnormality related diseases | 北京五和博澳药业股份有限公司 | 2025-03-21 | — | — | CN | claimed |
| EP-4501343-A1 | APPLICATION OF MULBERRY EXTRACT IN PREPARATION OF DRUG FOR TREATING ULCERATIVE COLITIS | Beijing Wehand-Bio Pharmaceutical Co., Ltd (CN) | 2025-02-05 | — | — | EP | claimed |
| US-20250018000-A1 | METHOD FOR TREATING AND PREVENTING ULCERATIVE COLITIS AND METHOD FOR DAI REDUCTION | BEIJING WEHAND-BIO PHARMACEUTICAL CO., LTD (CN) | 2025-01-16 | — | — | US | claimed |
| EP-4487861-A1 | USE OF MULBERRY TWIG ALKALOIDS IN PREPARATION OF DRUG FOR TREATING POLYCYSTIC OVARIAN SYNDROME | Beijing Wehand-Bio Pharmaceutical Co., Ltd (CN) | 2025-01-08 | — | — | EP | claimed |
| US-20240408162-A1 | Use of Extract from Morus alba L. in the Preparation of a Medicament for Preventing and/or Treating a Hepatobiliary Disease | BEIJING WEHAND-BIO PHARMACEUTICAL CO., LTD (CN) | 2024-12-12 | — | — | US | claimed |
| US-11865155-B2 | Plant extract obtained from Morus plant leaves which has an IC50 value to inhibit a-glucosidase I at a concentration of less than 90 uG/ml, compositions containing same, method of extraction and uses thereof | BOTANIC CENTURY (BEIJING) CO. LTD. | 2024-01-09 | — | — | US | claimed |
| US-5854272-A | 2-alkylpyrrolidines | NOVO NORDISK A/S (DK) | 1998-12-29 | — | — | US | claimed |
| EP-0884050-A1 | Use of 3,4-dihydroxy-2-hydroxymethylpyrrolidine for the treatment of diabetes | NOVO NORDISK A/S (DK) | 1998-12-16 | — | — | EP | claimed |
| EP-0858335-A1 | 2-ALKYLPYRROLIDINES | NOVO NORDISK A/S (DK) | 1998-08-19 | — | — | EP | claimed |
| WO-1997009040-A1 | 2-ALKYLPYRROLIDINES | NOVO NORDISK A/S (DK) | 1997-03-13 | — | — | WO | claimed |
| EP-0422975-B1 | Alpha-glucosidase inhibitors | MERRELL DOW PHARMA (US) | 1994-07-27 | — | — | EP | claimed |
| US-5097023-A | α-glucosidase inhibitors | MERRELL DOW PHARMACEUTICALS INC. (US) | 1992-03-17 | — | — | US | claimed |
| EP-0439444-A2 | Synthesis of chiral pyrrolidine and piperidine glycosidase inhibitors | MONSANTO COMPANY (US) | 1991-07-31 | — | — | EP | claimed |
| US-5013842-A | Synthesis of chiral pyrrolidine and piperidine glycosidase inhibitors | MONSANTO COMPANY (US) | 1991-05-07 | — | — | US | claimed |
| EP-0422307-A1 | Novel alpha-glucosidase inhibitors | MERRELL DOW PHARMACEUTICALS INC. (US) | 1991-04-17 | — | — | EP | claimed |
| EP-0422975-A1 | Alpha-glucosidase inhibitors | MERRELL DOW PHARMACEUTICALS INC. (US) | 1991-04-17 | — | — | EP | claimed |